Cecal Intubation Time in Colonoscopy: Prospective Clinical Trial

August 28, 2017 updated by: Ebubekir Gündeş, Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
During colonoscopy, body mass index, waist circumference and waist / hip ratio is the relationship between the cecal intubation difficulty aims to define.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Istanbul, Turkey
        • Recruiting
        • Eagle Run High Special Education and Research Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

There are cases of distant referral to the gastroenterology surgeon's polyclinic and indications for colonoscopy.

Description

Inclusion Criteria:

1. Above 18

Exclusion Criteria:

  1. Bad bowel preparation
  2. Failure of cecum intubation
  3. Inflammatory bowel disease
  4. Colectomy story

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
BMI <18.5 underweight (Group 1)
BMI was calculated as weight in kilograms divided by the square of height in meters. BMI <18.5 underweight (Group 1)
BMİ: 18.5 - 24.9 normal weight (Group 2)
BMI was calculated as weight in kilograms divided by the square of height in meters. BMİ: 18.5 - 24.9 normal weight (Group 2)
BMİ: 25- 29.9 overweight (Group 3)
BMI was calculated as weight in kilograms divided by the square of height in meters. BMİ: 25- 29.9 overweight (Group 3)
BMİ>30 obese (Group 4)
BMI was calculated as weight in kilograms divided by the square of height in meters. BMİ>30 obese (Group 4)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Body mass index (kg/m2)
Time Frame: 12/01/2016- 05/01/2017
12/01/2016- 05/01/2017
waist circumference (centimeter)
Time Frame: 12/01/2016- 05/01/2017
12/01/2016- 05/01/2017
waist / hip ratio
Time Frame: 12/01/2016- 05/01/2017
12/01/2016- 05/01/2017

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (Anticipated)

September 1, 2017

Study Completion (Anticipated)

September 15, 2017

Study Registration Dates

First Submitted

December 18, 2016

First Submitted That Met QC Criteria

December 21, 2016

First Posted (Estimate)

December 26, 2016

Study Record Updates

Last Update Posted (Actual)

August 29, 2017

Last Update Submitted That Met QC Criteria

August 28, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 2016.5/8-19

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endoscopy

Clinical Trials on colonoscopy

3
Subscribe